Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>
Related Articles
Trastuzumab Biosimilar May Alleviate Financial Toxicity in HER2+ Breast Cancer
NYU Langone's Perlmutter Cancer Center Buzzing With Breast Cancer Research
Emerging TNBC Agents Show Improved Patient Outcomes
Related Videos
Dr. Braunstein on the Bone Marrow Microenvironment in Multiple Myeloma
Dr. Weber on Adjuvant Pembrolizumab in Melanoma
Dr. Braunstein on Reclassifying Ultra High-Risk Smoldering Multiple Myeloma
OncologyLive > Vol. 20/No. 6 >

Perlmutter Earns NCI Comprehensive Cancer Center Designation

Published: Friday, Mar 15, 2019
Benjamin G. Neel, MD, PhD

Benjamin G. Neel, MD, PhD

The National Cancer Institute (NCI) has designated NYU Langone Health’s Laura and Isaac Perlmutter Cancer Center as a Comprehensive Cancer Center, the highest rank awarded by the NCI. Perlmutter joins an elite group of 50 cancer centers across the country that have earned this distinction.
... to read the full story
To Read the Full Story
REGISTER
LOG IN

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
 
x